tiprankstipranks
Trending News
More News >

Rhythm Biosciences Announces Proposed Issue of Securities

Story Highlights
Rhythm Biosciences Announces Proposed Issue of Securities

Don’t Miss TipRanks’ Half-Year Sale

Rhythm Biosciences Ltd. ( (AU:RHY) ) has provided an update.

Rhythm Biosciences Ltd. has announced a proposed issue of 483,871 ordinary fully paid securities, with the issue date set for June 2, 2025. This move is part of a placement or other type of issue, which could potentially enhance the company’s capital structure, providing additional resources for its operations and strategic initiatives in the biotechnology sector.

More about Rhythm Biosciences Ltd.

Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company is primarily engaged in creating products aimed at early detection and monitoring of cancer, with a market focus on improving patient outcomes through innovative diagnostic solutions.

Average Trading Volume: 232,721

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$18.84M

For an in-depth examination of RHY stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1